期刊文献+

SARS和MERS中和抗体假病毒检测方法的建立 被引量:19

Development of SARS and MERS Neutralization Methods Based on Pseudoviruses
原文传递
导出
摘要 严重急性呼吸综合征冠状病毒(SARS-CoV)和中东呼吸综合征冠状病毒(MERS-CoV)均属冠状病毒科(Coronaviridae),能够引起人类严重疾病,特别是SARS-CoV可以导致严重急性呼吸综合征,而且容易造成暴发式流行,引起社会恐慌。本研究利用含有SARS-CoV和MERS-CoV棘突蛋白(Spike protein,S)基因的表达质粒pcD-NA3.1-SS、pcDNA3.1-MS,成功构建了高滴度假病毒,在此基础上通过对病毒接种量进行优化,建立了稳定可靠的假病毒中和抗体检测方法,并通过检测SARS恢复期病人血清以及免疫后小鼠血清对方法的特异性、稳定性以及重复性进行分析,充分证明了该方法是有效的血清中和抗体的检测手段。本研究成功构建了不依赖于BSL-3级生物安全条件的SARS和MERS假病毒,不仅可应用于血清中和抗体检测,还为后续单克隆抗体及抗病毒药物筛选和评价、疫苗研发及病毒感染机制研究等奠定了基础。 The severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) belong to Coronaviridae, a family of enveloped, positive-sense, single-stranded RNA viruses that can cause serious human diseases.In particular, an outbreak of SARS caused by SARS-CoV can lead to social panic.We constructed stable pseudoviruses using pcDNA3.1-SS and pcDNA3.1-MS containing the S genes of SARS-CoV and MERS-CoV.On this basis, a method for detecting neutralizing antibodies was established by optimizing the inoculation amount of pseudoviruses.The specificity, stability and repeatability of this method were evaluated using the sera of patients convalescing from SARS and sera from im-munized mice.Results demonstrated that this method could be used to detect neutralizing antibodies in sera.Construction of SARS and MERS pseudoviruses independent from a Biological Safety Level-3 laboratory could be applied for detection of neutralizing antibodies from sera.Such construction could also lay a foundation for subsequent screening and evaluation of monoclonal antibodies and antiviral drugs, vaccine development, and research on the mechanism of viral infection.
作者 马建 贺鹏飞 赵晨燕 陈瑞峰 刘强 王佑春 黄维金 杨晓明 MA Jian;HE Pengfei;ZHAO Chenyan;CHEN Ruifeng;LIU Qiang;WANG Youchun;HUANG Weijin;YANG Xiaoming(Wuhan Institute of Biological Products Co.,LTD.,Wuhan 430070,China;National Institutes for Food and Drug Control,Beijing 100050,China)
出处 《病毒学报》 CAS CSCD 北大核心 2019年第2期189-195,共7页 Chinese Journal of Virology
基金 国家新药创制重大专项(项目号:2018ZX09101001) 题目:创新生物技术药评价及标准化关键技术研究~~
关键词 严重急性呼吸综合征(SARS) 中东呼吸综合征(MERS) 假病毒 中和抗体 The severe acute respiratory syndrome (SARS) Middle East respiratory syndrome (MERS) Pseudovirus Neutralizing antibody
  • 相关文献

参考文献7

二级参考文献63

  • 1广东省防治非典型肺炎科技攻关专题组,张勤奋,崔金明,黄小俊,林伟,谭冬艳,徐洁薇,杨艺峰,张景强,张欣,李晖,郑焕英,陈秋霞,郑夔,鄢心革,万卓越,黄吉城.严重急性呼吸综合征病毒的形态与发生[J].广东医学,2003,24(z1):3-6. 被引量:3
  • 2董关木,姚慧智.肾综合征出血热病毒蚀斑形态特性观察[J].中华实验和临床病毒学杂志,1993,7(2):202-203. 被引量:3
  • 3刘文雪,杨立宏,俞永新.肾综合征出血热疫苗大面积人群免疫的中和抗体应答[J].中国媒介生物学及控制杂志,1996,7(4):293-294. 被引量:6
  • 4陈丽娟 杨洁 和京梁 等.两种ELISA方法检测人血清中抗SARS冠状病毒IgG抗体[J].中华流行病学杂志,2004,25(2).
  • 5Editorial. Severe acute respiratory syndrome (SARS). J Clini Virol, 2003,28:245-247.
  • 6Sambrook J Fritsch E F Maniatis T 等.分子克隆实验指南:第3版[M].北京:科学出版社,2002..
  • 7Rota P A, Oberste M S, Monroe S S, et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome[J]. Science, 2003, 300(5624): 1394-1399.
  • 8Orellana C. Laboratory-acquired SARS raises worries on biosafety[J]. Lancet Infect Dis, 2004, 4:64.
  • 9Wu H S, Chiu S C, Tseng T C, et al. Serologic and molecular biologic methods for SARS-associated coronavirus infection, Taiwan[J]. Emerg Infect Dis, 2004,10:304-310.
  • 10Xiao X, Chakraborti S, Dimitrov A S, et al. The SARS-CoV S glycoprotein: expression and functional characterization[J]. Biochem Biophys Res Commun, 2003,312 (4) :1159-1164.

共引文献27

同被引文献155

引证文献19

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部